The GSE10645 PCa cohort results demonstrated that PCa patients in the high NRP1 expression group indicated shorter overall survival (OS) rate and cancer-specific survival (CSS) rate than those in the low NRP1 expression group (P < 0.0001; P < 0.0001; Fig. 1E, F). The gene discussed is NRP1; the disease is posterior cortical atrophy.